Zhu X - Search Results

1

Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.

Qiao Y, Zhu X, Li A, Yang S, Zhang J. Qiao Y, et al. Among authors: zhu x. Tumour Biol. 2016 Aug;37(8):10279-86. doi: 10.1007/s13277-016-4894-4. Epub 2016 Feb 2. Tumour Biol. 2016. PMID: 26838030

2

CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration.

Zheng J, Zhu X, Zhang J. Zheng J, et al. Among authors: zhu x. Biochem Biophys Res Commun. 2014 Mar 28;446(1):18-24. doi: 10.1016/j.bbrc.2014.01.172. Epub 2014 Feb 26. Biochem Biophys Res Commun. 2014. PMID: 24583128

3

CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.

Zhu X, Qiao Y, Liu W, Wang W, Shen H, Lu Y, Hao G, Zheng J, Tian Y. Zhu X, et al. Tumour Biol. 2016 Apr;37(4):4569-77. doi: 10.1007/s13277-015-4275-4. Epub 2015 Oct 27. Tumour Biol. 2016. PMID: 26503215

4

CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-κB pathway.

Wang C, Li A, Yang S, Qiao R, Zhu X, Zhang J. Wang C, et al. Among authors: zhu x. Biochem Biophys Res Commun. 2018 Apr 15;498(4):862-868. doi: 10.1016/j.bbrc.2018.03.071. Epub 2018 Mar 17. Biochem Biophys Res Commun. 2018. PMID: 29545183

5

Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.

Li A, Zhu X, Wang C, Yang S, Qiao Y, Qiao R, Zhang J. Li A, et al. Among authors: zhu x. Sci Rep. 2019 Mar 26;9(1):5166. doi: 10.1038/s41598-019-41660-w. Sci Rep. 2019. PMID: 30914736 Free PMC article.

6

S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.

Wang C, Zhu X, Li A, Yang S, Qiao R, Zhang J. Wang C, et al. Among authors: zhu x. Cancer Manag Res. 2019 Mar 27;11:2449-2456. doi: 10.2147/CMAR.S196450. eCollection 2019. Cancer Manag Res. 2019. PMID: 31118765 Free PMC article.

7

Evaluation of Urine NDRG1 as Noninvasive Biomarker for Bladder Cancer Diagnosis.

Sun YJ, Li AW, Zhang YC, Dai JH, Zhu X. Sun YJ, et al. Among authors: zhu x. Clin Lab. 2021 Mar 1;67(3). doi: 10.7754/Clin.Lab.2020.191020. Clin Lab. 2021. PMID: 33739027

8

Expression of CD4(+)CD25(high)CD127(low/-) regulatory T cells in transitional cell carcinoma patients and its significance.

Zhu X, Ma LL, Ye T. Zhu X, et al. J Clin Lab Anal. 2009;23(4):197-201. doi: 10.1002/jcla.20331. J Clin Lab Anal. 2009. PMID: 19623656 Free PMC article.

9

[Level of CD4(+) CD25(high) CD127(low/-) regulatory T cells in transitional cell carcinoma patients and its clinical significance].

Zhu X, Hu XZ, Ma LL, Tian Y. Zhu X, et al. Zhonghua Yi Xue Za Zhi. 2009 Aug 25;89(32):2269-72. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20095340 Chinese.

10

A case of recurrent Cronkhite-Canada syndrome containing colon cancer.

Zhu X, Shi H, Zhou X, Zong Y, Wang J, Xiao J, Zhang Y, Tian Y. Zhu X, et al. Int Surg. 2015 Mar;100(3):402-7. doi: 10.9738/INTSURG-D-14-00003.1. Int Surg. 2015. PMID: 25785317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,155 results

Search Page

Filters